Pharmacy Benefit Forecast for a New Interferon Beta-1a for the Treatment of Multiple Sclerosis: Development of a First-Line Decision Tool for Pharmacy-Budget Planning Using Administrative Claims Data

Detalles Bibliográficos
Autor principal: Meryer, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2003
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437187/
https://www.ncbi.nlm.nih.gov/pubmed/14613346
http://dx.doi.org/10.18553/jmcp.2003.9.2.168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437187/
https://www.ncbi.nlm.nih.gov/pubmed/14613346
http://dx.doi.org/10.18553/jmcp.2003.9.2.168

Ejemplares similares